Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen for post-exposure prevention of seasonal influenza in clustered close contacts
ChiCTR2300074385Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Aug 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lianhua Qingwen in influenza (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Secondary infection risk within 9 days. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
Lianhua Qingwen
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2300074385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074385.